Your browser has either disabled or does not support javascript. Javascript is required for full website experience.
Aptose Biosciences Inc.
APTO
$
4.49
-2.4%
Tue October 20th, 2020
14:26
Analysis
Aptose (APTO) Initiates Phase I a/b Study in Leukemia Patients
Zacks
Wed September 2nd, 2020
12:50
Analysis
Aptose Biosciences (APTO) Surges: Stock Moves 9.8% Higher
Zacks
+ 1 more
Mon August 24th, 2020
22:08
Analysis
Aptose Biosciences: Validation Impending For This Targeted Oncology Player
Seeking Alpha
Wed August 5th, 2020
18:02
Analysis
Aptose: Boring Today, But Things Could Get Exciting Later This Year
Seeking Alpha
04:15
Earnings
Analysis
Aptose Biosciences Inc. (APTO) CEO William Rice on Q2 2020 Results - Earnings Call Transcript
Seeking Alpha
Thu July 16th, 2020
19:31
Analysis
Why Aptose Biosciences Stock Sank Today
The Motley Fool
Mon June 29th, 2020
13:31
Press Releases
Analysis
Thinking about trading options or stock in Aptose Biosciences, Novavax, Inovio Pharmaceuticals, Ford Motor, or Carnival Corp?
PR Newswire
